30 January 2023 - A FDa official on Monday gave more clues for how the agency plans to wield new authority ...
8 December 2022 - The United States is a relatively free pricing market for pharmaceutical manufacturers to set list prices at ...
26 January 2023 - The US FDA has stated that AstraZeneca’s Evusheld (tixagevimab and cilgavimab) is not currently authorised for ...
25 January 2023 - As the 118th Congress convenes this month in Washington D.C., many pundits and advocates have little ...
25 January 2023 - A critical pathway that generics and biosimilars manufacturers have used to circumvent patent thickets has been “skinny ...
24 January 2023 - Anti-abortion physicians are suing to overturn the FDA’s approval of mifepristone, which dates back more than two ...
23 January 2023 - In an unexpected move, the FDA will continue to apply exclusive marketing rights for so called ...
18 January 2023 - A FDA program markedly cut the time and cost of bringing to market new drugs, without ...
13 January 2022 - In 2022, several bills were introduced in Congress to revamp US intellectual property law. ...
9 January 2023 - Although artificial intelligence is entering health care with great promise, clinical artificial intelligence tools are prone ...
28 December 2022 - For medical devices in the Breakthrough Devices Program, 2022 has been a breakout year. ...
29 December 2022 - The US FDA failed to adhere to its own guidance and internal practices during the approval ...
23 December 2022 - The FDA on Friday altered the language attached to emergency contraceptive pills to clarify that they ...
21 December 2022 - The US FDA is aiming to improve the quality of real world evidence used in regulatory ...
21 December 2022 - The FDA considers ageing to be a natural process. This makes it difficult to get FDA approval ...